CynthiaE.HerzogMD

Pediatric Hematology & Oncology • Houston, TX

Professor of Pediatrics The University of Texas MD Anderson Cancer Center

Join to view full profile

Dr. Herzog is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Herzog's full profile

Already have an account?

Office
1515 Holcombe Blvd
Houston, TX 77030
Phone+1 713-792-6161

Education & Training

National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 1988 - 1992
University of Texas Southwestern Medical CenterResidency, Pediatrics, 1986 - 1988
University of Texas Southwestern Medical CenterInternship, Pediatrics, 1985 - 1986
University of Texas Medical Branch School of MedicineClass of 1985

Certifications & Licensure

FL State Medical License 2021 - Present
TN State Medical License 2024 - 2026
AZ State Medical License 2024 - 2025
GA State Medical License 2024 - 2025
MS State Medical License 2024 - 2025
OK State Medical License 2020 - 2025
TX State Medical License 1987 - 2025
AL State Medical License 2024 - 2024
LA State Medical License 2024 - 2024
WA State Medical License 2024 - 2024
American Board of Pediatrics Pediatric Hematology-Oncology
Join now to see all

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed Malignancies Start of enrollment: 2000 Jun 01
Completed
Phase 2
Aerosol L9-NC and Temozolomide in Ewing's Sarcoma Start of enrollment: 2006 Jun 01
Completed
Phase 1, Phase 2
External Beam Radiation Therapy and Cetuximab Followed by Irinotecan and Cetuximab for Children and Young Adults With Newly Diagnosed Diffuse Pontine Tumors and High-Grade Astrocytomas Start of enrollment: 2009 Oct 30
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Clinical Study of Vorinostat in Combination With Etoposide in Pediatric Patients < 21 Years at Diagnosis With Refractory Solid Tumors Start of enrollment: 2011 Feb 09
Completed
Phase 1, Phase 2
Cyclophosphamide, Topotecan, and Bevacizumab (CTB) in Patients With Relapsed/Refractory Ewing's Sarcoma and Neuroblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
Ph 1 Study of ADI PEG 20 in Pediatric Subjects Who Are Argininosuccinate Synthetase (ASS) Deficient Start of enrollment: 2011 Dec 01
Completed
Phase 1
Join now to see all

Publications & Presentations

PubMed

57 citations
Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma.
Birgit Geoerger, Christophe Bergeron, Lia Gore, Leonard S. Sender, Ira J. Dunkel
European Journal of Cancer. 2017-11-01
12 citations
Evaluation of a potential regulatory role for inverted CCAAT boxes in the human topoisomerase IIα promoter
Cynthia E. Herzog, Leonard A. Zwelling
Biochemical and Biophysical Research Communications. 1997-03-27
38 citations
Primary malignant pancreatic neoplasms in children and adolescents: A 20 year experience ☆
Yesenia Rojas, Carla L. Warneke, Chetan Dhamne, KuoJen Tsao, Jed G. Nuchtern
Journal of Pediatric Surgery. 2012-12-01

Journal Articles

Multimodality Treatment of Desmoplastic Small Round Cell Tumor: Chemotherapy and Complete Cytoreductive Surgery Improve Patient Survival
Alexander J Lazar, Joseph A Ludwig, Cynthia E Herzog, Raphael E Pollock, Clinical Cancer Research

Professional Memberships

American Society of Clinical Oncology - ASCO
Member